GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Sale Of Investment

Kingworld Medicines Group (HKSE:01110) Sale Of Investment : HK$0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Sale Of Investment?

Kingworld Medicines Group's sale of investment for the six months ended in Jun. 2024 was HK$0 Mil. It means Kingworld Medicines Group gained HK$0 Mil from selling investments. Kingworld Medicines Group's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

Compared with last quarter (HK$0 Mil in Dec. 2023 ), Kingworld Medicines Group gained the same money from selling investments in Jun. 2024 (HK$0 Mil).


Kingworld Medicines Group Sale Of Investment Historical Data

The historical data trend for Kingworld Medicines Group's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Sale Of Investment Chart

Kingworld Medicines Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 811.76 234.12 0.12 - 18.28

Kingworld Medicines Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kingworld Medicines Group Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kingworld Medicines Group Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Executives
Chan Lok San 2101 Beneficial owner
Zhao Li Sheng 2101 Beneficial owner
Sinopharm Capital Limited 2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p. 2101 Beneficial owner
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you

Kingworld Medicines Group Headlines

No Headlines